InterCure Ltd. (NASDAQ:INCR) Short Interest Update

InterCure Ltd. (NASDAQ:INCR) was the recipient of a significant decline in short interest in February. As of February 15th, there was short interest totalling 27,400 shares, a decline of 33.3% from the January 31st total of 41,100 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average trading volume of 32,700 shares, the days-to-cover ratio is currently 0.8 days.

InterCure Stock Down 0.6 %

Shares of NASDAQ:INCR opened at $1.57 on Friday. InterCure has a twelve month low of $1.17 and a twelve month high of $3.72. The stock’s 50 day moving average is $1.66 and its 200-day moving average is $1.70. The company has a quick ratio of 1.15, a current ratio of 1.78 and a debt-to-equity ratio of 0.15.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of INCR. Jane Street Group LLC acquired a new position in shares of InterCure during the third quarter valued at about $49,000. Virtu Financial LLC bought a new position in InterCure in the 3rd quarter valued at about $43,000. Finally, Moore Capital Management LP acquired a new position in InterCure during the 4th quarter valued at about $156,000. Institutional investors and hedge funds own 8.34% of the company’s stock.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.